SCHEMBL31415955

SCHEMBL31415955

CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ NTSR1 P30989 10/20 0.58
▸ NTSR2 O95665 8/20 0.58
▸ NPY1R P25929 4/20 0.57
▸ SORT1 Q99523 6/20 0.57
▸ MAPK8 P45983 1/20 0.55
▸ MAPK9 P45984 1/20 0.55
▸ MAPK10 P53779 1/20 0.55
▸ NPY2R P49146 4/20 0.55
▸ NPY4R P50391 4/20 0.55
▸ NPY5R Q15761 4/20 0.55
▸ EPHA2 P29317 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31307264 0.87 NTSR2 (0.56) NTSR1NTSR2NPY1RSORT1NPY2R
SCHEMBL9807257 0.86 NTSR1 (0.62) NTSR1NTSR2NPY1RSORT1EPHA2
SCHEMBL30312779 0.85 NTSR1 (0.72) NTSR1NTSR2NPY1RSORT1
SCHEMBL30512559 0.85 EPHA2 (0.55) NTSR1NTSR2NPY1RSORT1MAPK8
SCHEMBL31005063 0.85 NPY2R (0.62) NTSR1NTSR2NPY1RMAPK8MAPK9
SCHEMBL30512543 0.85 NTSR2 (0.65) NTSR1NTSR2NPY1RSORT1NPY2R
SCHEMBL30457966 0.85 MAPK8 (0.53) NTSR1NTSR2NPY1RSORT1MAPK8
SCHEMBL30880900 0.84 MAPK8 (0.60) NTSR1NTSR2NPY1RMAPK8MAPK9
SCHEMBL30864885 0.83 NTSR1 (0.78) NTSR1NTSR2SORT1
SCHEMBL31182485 0.83 RAMP3 (0.62) NPY1RNPY2RNPY4RNPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025002590-A1 TISSUE MHC CLASS I IMMUNOPEPTIDE PATTERN DEDICATED FOR GENERATION OF ANTI-CANCER VACCINES AGAINST NON-SMALL CELL LUNG CANCER (NSCLC), IDENTIFICATION AND ISOLATION OF NSCLC SPECIFIC T CELLS IN HUMANS UNIWERSYTET GDÁNSKI (PL) 2025-01-02 — — WO claimed
Send feedback